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Nocturnal Asthma*
32-Adrenoceptors on Peripheral Mononuclear
Leukocytes, cAMP- and Cortlsol’Plasma
Concentrations
Ekkehard Haen, M.D., M.S.; Rainer Hauck, M.D.;
Hans Peter Emslander, M.D.; Irmgard Langenmar, M.D.;
Bernhard Liebi, M.D.; Jochen Schopohi, M.D.; Jorg Remien, M.D.; and
G#{252}nterFruhmann, M.D., FC.C.P
To evaluate pathophysiologic mechanisms of the predomi-
nantly nocturnal complaints in atopic bronchial asthma, the
expression and function of 5-adrenoceptors on peripheral
mononuclear leukocytes (pMNL), the cAMP-as well as
the cortisol--plasma concentrations were studied in eight
healthy men and ten so far untreated male asthmatic
patients at 4-h intervals for 24 h. No difference was seen in
the ,-adrenoceptor density (Bmax) on pMNL between
healthy and asthmatic men (24-h means ± SE: 908 ±59 sites
per cell and 821 ±54 sites per cell, respectively). The
equilibrium dissociation constant (Kd), however, was signif-
icantly higher in the asthmatic patients (24-h mean ± SE:
8.8± 1.2 pmol/L vs 3.0±0.2 pmol/L in healthy men,
p<O.000l), which is equivalent to a lower affinity of the -
adrenoceptors for the radioligand “iodocyanopindolol.
Bmax showed a statistically significant circadian variation,
but Kd did not. The circadian variation in Bmax was
reflected in the basal intracellular cyclic adenosine-mono-
phosphate (cAMP) content of the cells investigated. High
Kd values (equivalent to low receptor affinities) tended to
be associated with small increases ofthe intracellular cAMP
content after in vitro stimulation by 10 molfL isoprenaline
(isoproterenol) (24-h mean ± SE: 1.4 ±0.2 pmol/ 10 cells;
r -0.529, pO.05 at r -0.549, n10). Plasma cAMP
concentrations were found to be significantly lower in the
asthmatic patients (24-h means±SE: 22.9± 1.3 nmol/L vs
29.1 ± 1.1 nmol/L, p <0.0001). Plasma cortisol concentra-
tions were significantly higher in the asthmatic patients (24-
h means±SE: 0.500±0.084 .tmol/L vs 0.319±0.063
unol/L). The results support the hypothesis that a lesion
of the -adrenergic system contributes to the pathophysi-
ology ofatopicbronchial asthma. Inthe patients investigated
in this study, such a lesion could be demonstrated in the
affinity rather than in the number of (1-adrenoceptors
expressed on peripheral cells of the immune system
(pMNL). According to present-day knowledge of adrenergic
effects on pMNL, such an affinity decrease of (11-adreno-
ceptors could account Ibr overshooting immune reponses.
In association with other factors influencing respiratory
function, it could be responsible fir the predominantly
nocturnal complaints in atopic bmnchial asthma. Plasma
cortisol concentrations did not appear to be related to the
principal cause of”nocturnal asthma” they rather reflected
an endogenous defense mechanism to the disease.
(Chest 1991; 100:1239-45)
ANOVAanalysis of variance; Bmax 1-adrenoceptor den-
sity; cAMPcydic adenosine monophosphate; IBMX isobutyl
methylxanthin; ‘I-CYP ‘‘iodocyanopindolol; Kdequilib-
rium dissociation constant; PDE phosphodiesterase; PEF
peak expiratory flow; pMNLperipheral mononuclear leuko-
cytes
B ronchial asthma is characterized by refractoriness
against 3-adrenergic stimuli.’ Drugs amplifying
the sympathetic tone (3-sympathomimetic drugs, me-
thyixanthines) are most effective in this disorder,2 so
that a disturbance of the expression and/or function of
3-adrenoceptors was suggested as an underlying
cause . ‘ This theory has been the subject of intense
investigation; however, it has not been possible to
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either reject or substantiate it clearly. We are inter-
ested in the circadian variation of asthmatic attacks.
Circadian variations in the excretion of catechola-
mines, in plasma adrenaline concentration, and in
plasma cyclic adenosine monophosphate (cAMP) con-
centration have already been described7’#{176} with low
values in the early morning matching the time of
increased asthmatic symptoms. As well as these var-
iables, the number and affinity of 32-adrenoceptors
are necessary to fully describe the sympathetic tone
and its influence on the bronchial tone. Recently we
observed a circadian variation in the 32-adrenoceptor
density (Bmax) expressed on peripheral mononuclear
leukocytes (pMNL) of healthy men.” A reduced 
adrenoceptor density in asthmatic patients has been
assumed’2’3 but not yet substantiated convincingly.
Previous investigations may have been biased by
pretreatment of the patients under investigation, by
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circadian variations of the physiologic variables stud-
ied, by differences between male and female sub-
jects,” and by a conceptual error in the analysis of
radioligand receptor assays.  On the other hand,
the circadian variations of plasma cortisol concentra-
tions are also assumed to contribute to nocturnal
asthma.51617 We therefore studied the expression of
132-adrenoceptors on pMNL, the isoprenaline-induced
intracellular cAMP production in these cells, and the
cAMP as well as the cortisol plasma concentrations of
so far untreated asthmatic men for 24 h. As cells of
the immune system, pMNL might be directly involved
in the pathophysiology of atopic bronchial asthma.
Like bronchial tissue, they bear 3-adrenoceptors of
the 32-type.’8 These cells may be simply and repeat-
edly collected without undue discomfort for the pa-
tient. They are therefore widely used in clinical studies
on receptor disturbances in bronchial asthma.’
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FIGURE 1 . Mean circadian variation in peak expiratory flow (top
panel) and in oscillatory airway resistance (bottom panel) of five so
far untreated male asthmatic patients.
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MATERIALS AND METHODS
At 4-h intervals, 20 ml of venous blood was drawn from the
antecubital vein of eight healthy men and ten male asthmatic
patients. Seven healthy men and two asthmatic patients were
hospitalized in the Clinical Research Unit of the Walther-Straub-
Institute; one healthy man and three asthmatic patients were
hospitalized in the I. Medical Clinic of the Technical University,
the other five patients were hospitalized in the I. Medical Clinic
Grofihadern of the Ludwig-Maximiians-University of Munich.
Collection of blood, lung function testing, and handling of blood
specimens were always done by the staff of the Walther-Straub-
Institute. All laboratory tests were performed in the Walther.
Straub-Institute; only plasma cortisol was assayed in Dr. Schopohl’s
laboratory.
The healthy subjects (22 to 34 years ofage) had a negative history
and showed no signs of allergic, pulmonary, cardiac, renal, and
hepatic disease, nor ofany other disease by clinical inspection. Total
plasma 1gB concentrations were below 120 kU/L. The asthmatic
patients were 19 to 33 years ofage. They had never been consistently
treated for their complaints, which implies that their asthma was of
a mild type. Some of them had occasionally used medications,
inhaled -sympathomimetic or vagolytic drugs (less than one or two
puffs within three weeks), and/or antihistamines, but usually over-
came their symptoms without medication. They were referred from
private practices to the participating hospitals for diagnostic check-
ups. They complained of breathlessness and coughing predomi-
nantly at nighttime. Their respiratory function was monitored over
the period under investigation by i computer.based bedside spiro-
meter providing full flow/volume spirometry (Spiropro 3000, Gans-
horn Electronic GmbH, MOnnerstadtlFRG) in five patients (pa-
tients hospitalized at the I. Medical Clinic of the Technical
University and at the Clinical Research Unit ofthe Walther-Straub-
Institute) and by oscillatory aiiway resistance (Raw, Siregnost FD
5, Siemens AG, ErlangenfFRG) in the other five patients (hospital-
ized at the I. Medical Clinic Grofihadern ofthe Ludwigs-Maximil-
inns-University); measurements were performed immediately after
drawing blood. The atopic nature of their asthma was verified by
anamnesis, positive skin tests, demonstration of specific IgE anti-
bodies, and by exposure to the antigen in question. The repeated
assessment of respiratory function at 4-h intervals allowed the
documentation of bronchial obstruction and its spontaneous revers-
ibility (Fig 1).
The study was approved by the ethical committee of the hospital
of the Technical University of Munich and informed consent was
obtained. The subjects were hospitalized for the full length of the
investigation. They continued to follow their regular lifestyle, which
they had recorded for the week preceding the study. On the average,
they slept from 11 PM to 7 AM, and meals were served at 8 AM,
11:30 AM, and 5:30 psi. During the day, the subjects did not stay in
bed, but either did some paper work, read, or went for short walks.
Blood was drawn after 30 mm of rest in the supine position. No
drugs were taken.
Directly after venipuncture, intact pMNL were harvested by
density centrifugation (using Lympho-paque, Nyegaard & Co. AS,
Oslo/Norway). The expression of fI,-adrenoceptors was studied for
each time point in radioreceptor assays as described elsewhere.”
In brief, pMNL were incubated for 2 h at 37#{176}Cwith 12 concentra-
tions of (-)-“iodocyanopindolol (nICYP, Amersham Buchler,
Braunschweig(FRG)in the rangeofl.0 to 150.OpmolfL to determine
the number of high affinity binding sites (Bmax) and their equilib-
rium dissociation constant (Kd). Nonspecific binding was deter-
mined in parallel incubations with 10’ mollL(-)-timolol. Pipetting
was performed (by a Tecan Robotic Sample Processor Model 5052,
dual arm system, Tecan AG FrankfLIrt/FRG).’ A binding equation
for two independent classes of binding sites was fitted to the data,
using a nonlinear iteration procedure.’”
The function of 3,-adrenoceptors on pMNL was tested in the
asthmatic patients by stimulating the intracellular cAMP content
with 10-v mol/L isoprenaline (isoproterenol) over basal values
(incubation with buffer) for 10 mm at 37#{176}C.The cells were
preincubated for 30 mm at room temperature with 10 mol/L
isobutylmethylxanthin (IBMi() to inhibit the degradation of intra-
cellularly formed cAMP by the enzyme phosphodiesterase (PDE).
The incubation with isoprenaline was stopped by placing the cell
suspensions for 5 mm in boiling water to rupture the cells. Cell
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FIGURE 3. Mean circadian variation in the apparent
equilibrium dissociation constant (Kd) for the radioli-
gand “iodocyanopindolol of ,-adrenoceptors ex-
pressed on peripheral mononuclearleukocytes (pMNL)
of 10 so far untreated male asthmatic patients, 19 to 33
years ofage, and 8 healthy men, 22 to 34 years of age.
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FIGURE 2. Mean circadian variation in the expression
of ,-adrenoceptors (Bmax) on peripheral mononuclear
leukocytes (pMNL) of 10 so far untreated male asth-
matic patients, 19 to 33 years of age, and 8 healthy
men, 22 to 34 years of age.
particulates were centrifuged for 5 mm at 15,000g and the super-
natant stored at - 20#{176}Cuntil determination of the CAMP content.
Intracellular cAMP, plasma cAMP, and plasma cortisol were deter-
mined by radioimmunoassay (Amersham Buchier, Braunschweig/
FRG and DRG Instruments GmbH, MarburgfFRG, respectively).
Mean values are given with their standard errors (SE). The 24-h
mean was defined as the mean of each set of raw data within 24 h,
the CirCadian range as the difference between its maximal and
minimal value, and the circadian variation as the time-specified
pattern of variation observed over 24 h. Time of day effects were
statistically validated by an analysis of variance (ANOVA) with
subjects and time of day as components. Correlations between
mean values were tested by linear regression analysis. To test for
differences between asthmatic patients and healthy men, a Students
t test was used. The significance level used was a = 0.05.
RESULTS
Respiratory function tests revealed a mild form of
asthma in the ten male patients (peak expiratory flow
[PEF] 24-h mean±SE: 494±21 Llmin, Raw 24-h
mean ± SE: 3.8 ± 0.22 kPa x ilL). All of the asthma
patients, however, showed a marked nocturnal dip,
even if their respiratory function was in the normal
range during daytime. This was apparent in both PEF
(17.7 ± 4.8 percent of the 24-h mean at 6 AM, top
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panel in Fig 1) and oscillatory airway resistance
(18.4 ± 5.9 percent of the 24-h mean at 2 AM , bottom
panel in Fig 1). The spontaneous reversibility of the
nocturnal dip was demonstrated in each patient.
Statistically significant time of day effects were
observed in the circadian variation of the 32-adreno-
ceptor density on pMNL in the healthy controls
(ANOVA; p<O.OOl; 24-h mean ± SE: 908 ± 59 sites per
cell; circadian range: 71.6 to 126.9 percent of the
24-h mean), whereas in the asthmatic patients, these
effects were not statistically significant (ANOVA:
p = 0.077; 24-h mean ± SE: 821 ± 54 sites per cell;
circadian range: 69.3 to 133.7 percent of the 24-h
mean; Fig 2). In both groups, 32-adrenoceptor density
was lowest around midnight. There were no statisti-
cally significant differences between healthy and asth-
matic subjects in Bmax.
No statistically significant time of day effects were
observed in the circadian variation of the apparent
equilibrium dissociation constant Kd representing the
affinity of the 2-adrenoceptors for the radioligand
2.5ICYP In the asthmatic patients, however, the a.ffin-
ity was decreased over the whole study period (which
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FIGURE 4. Mean circadian variation in the basal cyclic
adenosine monophosphate (cAMP) content of periph-
eral mononuclear leukocytes (pMNL) of 10 so far
untreated male asthmatic patients, 19 to 33 years of
age, and its stimulation by 10 mol/L isoprenaline.
is equivalent to an increased Kd value, Fig 3): The
24-h mean ± SE was 8.8 ± 1 .2 pmol/L in the asthmatic
patients as compared with 3.0 ± 0.2 pmol/L in the
healthy controls (p<O.0001).
The basal intracellular cAMP content of pMNL
derived from asthmatic patients reflected the circadian
variation in the (32-adrenoceptor density expressed on
these cells (ANOVA: p<O.Ol; 24-h mean±SE:
4.4 ± 0.3 pmol/1O cells; circadian range: 70.2 to 131.9
percent of the 24-h mean, Fig 4). After isoprenaline
stimulation, the 24-h mean of the intracellular cAMP
content increased by 1 .4 ± 0.2 pmol/1O” cells (24-h
mean ± SE, circadian range: 63.2 to 154.9 percent of
the 24-h mean, Fig 4). Expressed as pmol/1O cells,
stimulation was highest at 6 AM and lowest at 2 PM;
expressed as a percentage of the basal value, stimula-
tion was highest at the time of lowest basal value (10
PM: 168.8 percent of basal value) and lowest at the
time of highest basal value (2 PM: 120.8 and 118.6
percent of basal value). When the 24-h means were
fitted by a linear regression, 28 percent of the total
variation could be explained by a negative correlation
healthy men
---- asthmatic patients
L #{149}L
I t . , , , ,
1400 1800 22#{176}c 0200 0600 1000 1400 1800
time ( h )
between the stimulation of intracellular cAMP and
the apparent equilibrium dissociation constant Kd; ie,
high Kd values (equivalent to low receptor affinities)
tended to be associated with small increases of the
intracellular cAMP content after in vitm stimulation
by isoprenaline. The correlation coefficient was just
below the significance level (r = - 0.529; p = 0.05 at
r = - 0.549, n = 10). The correlation between the stim-
ulation of intracellular cAMP and Bmax was not
statistically significant (r = 0.0996).
Statistically significant time ofday effects could also
be demonstrated in the circadian variation of cAMP
plasma concentrations in both healthy subjects
(ANOVA: p<O.05) and asthmatic patients (ANOVA:
p<O.05). The values were significantly lower for the
asthmatic patients (24-h mean ± SE: 22.9 ± 1 .3 nmol/
L) compared with the healthy controls (24-h
mean ± SE: 29. 1 ± 1 . 1 nmol/L, p<O.000l, Fig 5). The
circadian range for this variable was similar in both
groups (healthy subjects: 87.1 to 117.5 percent of
24-h mean; asthmatic patients: 86.3 to 108.0 percent
of 24-h mean).
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The circadian variation of plasma cortisol concen-
trations showed statistically significant time of day
effects in both healthy men (ANOVA: p<O.OOl) and
asthmatic subjects (ANOVA: p<O.OOl, Fig 6). The
24-h mean was significantly lower in the healthy
controls (mean ± SE: 0.319 ± 0.063 amolfL) compared
with the asthmatic patients (mean ± SE: 0.500 ± 0.084
pmol/L, p<O.Ol). Plasma cortisol concentrations
dropped at night to 0.030 ± 0.014 pmol/L in the
healthy controls, but only to 0. 135 ± 0.039 mol/L in
the asthmatic patients. The circadian range was 9.6 to
182.9 percent of the 24-h mean in the healthy men,
andjust 27.6 to 148.2 percent ofthe 24-h mean in the
asthmatic patients.
DISCUSSION
Studies on the pathophysiology ofbronchial asthma
are often biased by some kind of pretreatment of the
patients under investigation. In this study, particular
care was taken in the selection of untreated patients.
To the best ofour knowledge, expression and function
of32-adrenoceptors on pMNL were not influenced by
any kind of (pre)treatment. These patients are rather
rare, at least in academic centers. It has to be pointed
out that, since the patients were able to manage their
disease without any drugs, their disease was mild. The
clinical diagnosis, however, was unequivocally estab-
lished in each case. The conclusions that follow apply,
strictly speaking, just to this group of patients. They
suggest an important aspect of the multifunctional
pathophysiologic condition of bronchial asthma that
may possibly only be observed in untreated subjects.
Plasma cortisol was originally determined as a marker
for the circadian system . Results demonstrated that
the circadian system of each individual in this study
was synchronized to the 24-h day.
It has been suggested that bronchial asthma is
caused by a malfunction of I3’ Such as
malfunction was often assumed to be a reduced
receptor number’2’3 whereas the original hypothesis
included all kinds of (3-adrenoceptor disturbances,
even adenylate cyclase insufficiency.’ In our study, no
difference in the number of 32-adrenoceptor sites
expressed on pMNL could be observed between
healthy men and untreated male asthmatic patients of
the same age group. We did detect, however, a reduced
affinity of these 32-adrenoceptors for the radioligand
asICYP in our asthmatic patients. This indicates a
conformational change of the receptor protein, al-
though it does not prove at present, a reduced affinity
for the physiologic ligand adrenaline. ‘I-CYP is a
sympathetic antagonist that might bind to a site on
the receptor protein different from the agonist binding
site. A reduction in the affinity of 32-adrenoceptors
for ‘I-CYP without concomitant change in the 32-
adrenoceptor density has already been reported by
Liebi et aP under the influence of reducing agents.
Although the significance of this latter finding for the
pathophysiologic condition of bronchial asthma is not
clear at present, it demonstrates yet another example
of affinity changes in 32-adrenoceptors.
In vitro stimulation of intracellular cAMP produc-
tion is used to test the function of 2-adrenoceptors
determined by radioreceptor assays. Both experi-
ments are performed using the same pMNL cell
suspension. In this study, the increase of intracellular
cAMP tended to be negatively correlated to the
equilibrium dissociation constant Kd-in other words,
the lower the affinity of 32-adrenoceptors, the lower
(in the same cells) the intracellular increase of cAMP
after in vitro stimulation by isoprenaline.
Plasma cAMP concentrations in our asthmatic pa-
tients were significantly lower than in our healthy
controls. According to Holmegaard, 50 percent of
plasma cAMP results from leakage out ofcells express-
ing 3-adrenoceptors; the other 50 percent presumably
stem from kidney cells under stimulation by parathor-
mone. Plasma cAMP may therefore be used as a
 © 1991 American College of Chest Physicians
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crude, integral marker of the 3-adrenergic tone.
Although this has been done in several leading
publications, to our knowledge, data for healthy sub-
jects and asthmatic patients have been never compared
in the same study. Barnes et al gave data for five
asthmatic men whose bronchodilator medication was
stopped 48 h before the investigation. According to
PEF measurements, the patients were suffering from
a more severe bronchial asthma than our patients;
their plasma cAMP concentrations were even lower (8
to 16 nmoIIL) than plasma cAMP in our patients.
Mikuni et al’#{176}studied 13 healthy male subjects whose
cAMP plasma concentrations were lower than in our
healthy control group, but still higher than in the
asthmatic patients of Barnes et al (13.2 to 19.3 nmol/
L).
How could an affinity decrease of 32-adrenoceptors
throughout 24 h contribute to “nocturnal asthma” in
our patients? At night, a fall in plasma adrenaline7’#{176}
and cortisol5”6”7 concentrations as well as in the
number of 32-adrenoceptors (this study) diminish
physiologically the effectiveness of endogenous bron-
chodilating mechanisms, whereas the activity of en-
dogenous bronchoconstrictors, such as the parasym-
pathetic system2 and/or the histamine release,9 is
increased. At that time, the affinity decrease of 2-
adrenoceptors cannot be counterbalanced as effi-
ciently as during the daytime, thus giving rise to
asthmatic attacks.
In this study, the expression and function of 32-
adrenoceptors was studied on white blood cells that
may be easily and repeatedly collected without causing
undue discomfort to the patient. Many investigations
on the possible role of -adrenoceptors in atopic
bronchial asthma used pMNL as a kind oftissue model
for bronchial lissue,’3’ since it is impossible to
obtain human lung tissue for routine analyses, espe-
cially not for repeated investigations on the same
individual as in this study. The changes observed on
these cells are assumed to occur in the same way on
132-adrenoceptors in bronchial tissue. In general, this
working hypothesis is not even mentioned explicitly.
However, it has not yet been convincingly demon-
strated that this approach is actually valid. There are
many good arguments in favor of this assumption;tm
however, there are also reports opposed to it.tm It is
unlikely that the characteristics of 32-adrenoceptors
vary under physiologic conditions among receptors
expressed in different tissues of the body. Likewise
drugs should have the same effects on these receptors
as long as they are administered systemically. It is
feasible, however, that pathologic mechanisms may
affect just one population of (32-adrenoceptors.
With regard to this study, such considerations are
less important. The reduced affinity of 2-adrenocep-
tors was studied in cells collected from blood. If such
a reduced affinity is biologically significant, it should
result in a reduced formation of intracellular cAMP,
which in turn, may leak to a lesser extent out of these
cells into the surrounding plasma. In this study, both
the reduced affinity as well as the reduced cAMP
concentration in plasma could be demonstrated in the
same individuals; in other words, a reduced sympa-
thetic tone was demonstrated in two physiologic
variables directly interrelated, notwithstanding the
type of cells investigated. Even if our results simply
indicate a reduced sympathetic influence on lympho-
cytes, they demonstrate that at least pMNL are
exposed to a reduced sympathetic tone in asthmatic
patients.
Moreover, such an interpretation might be even
more challenging. Atopic bronchial asthma is an aller-
gic and inflammatory disease involving immune reac-
tions. The pMNL do take part in these reactions. The
impact ofthe sympathetic system on immune functions
exerted by pMNL has been under investigation. A
clear-cut concept has not yet emerged, but there has
been much speculation, mostly based on investigations
of the role of intracellular cAMP levels. Available
evidence points in general to an inhibition of immune
functions by an increasing intracellular cAMP con-
tent. A reduction in affinity of 32-adrenoceptors
expressed on pMNL would therefore reduce this
inhibiting action leading to overshooting immune
reactions: allergy and inflammation.
Decreasing cortisol plasma concentrations are gen-
erally discussed as contributing to “nocturnal asthma:’
However, no comparison has been made so far be-
tween healthy subjects and asthmatic patients in the
same study. We were unable to trace lower cortisol
plasma concentrations at night in our asthmatic pa-
tients than in our healthy controls. On the contrary,
plasma cortisol concentrations were found to be
higher; there was a small, but statistically significant
difference in the 24-h mean and in the early morning
values. We do interpret the higher cortisol secretion
in our asthmatic patients as an endogenous defense
reaction against the disease. It has been suggested
that the administration of glucocorticoids may upreg-
ulate the expression of (3-adrenoceptors.3 The ele-
vated cortisol concentration observed in our asthmatic
patients would then be necessary to maintain the 
adrenoceptor density in the range observed in our
healthy controls. Ifthis assumption is not correct, then
physiologic concentrations of glucocorticoids do not
have any effect on the number of 3-adrenoceptors.
The “upregnlation’ observed after steroid administra-
lion could be a misinterpretation of the circadian
variation in the expression of 32-adrenoceptors on
pMNL: Brodde et aP administered prednisone at
9 AM and determined the steroid effect on the 
adrenoceptor density in the afternoon.
 © 1991 American College of Chest Physicians
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The results of this study support the hypothesis of
a 3-adrenergic lesion contributing to the pathophysi-
ologic condition of atopic bronchial asthma. In our
patients, this lesion could be demonstrated in the
affinity rather than in the number of f32-adrenoceptors.
If this 3-adrenergic lesion does not lead to a general
reduction in sympathetic tone but rather affects only
pMNL, a disturbed modulation ofimmune responses
by the sympathetic system should be considered in
atopic bmnchial asthma.
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